Pulse Biosciences (PLSE) FCF Margin (2021 - 2025)

Name: Pulse Biosciences (PLSE) FCF Margin (2021 - 2025) | Business Quant
Creator: Business Quant

Pulse Biosciences' quarterly FCF Margin came in at 15377.91% in Q3 2025, down 117.29% quarter-over-quarter from 88955.56% in Q4 2022.

Pulse Biosciences has reported FCF Margin for 3 years, with the latest figure at 15377.91% in Q3 2025.

For the quarter ending Q3 2025, FCF Margin changed N/A year-over-year to 15377.91%; the trailing twelve-month figure through Sep 2025 stood at 56598.84% (changed N/A YoY), and the FY2022 full-year result was 6773.43%, down 292759.0% from the prior year.
FCF Margin for Q3 2025 stood at 15377.91%, down from 88955.56% in the prior quarter.
The five-year high for FCF Margin was 88955.56% in Q4 2022, with the low at 15377.91% in Q3 2025.
Average FCF Margin over 3 years is 10308.21%, with a median of 2964.07% recorded in 2021.
Peak annual rise in FCF Margin reached 9047546 bps in 2022, while the deepest fall reached 9047546 bps in 2022.
Tracing PLSE's FCF Margin over 3 years: stood at 1519.91% in 2021, then soared by 5953 bps to 88955.56% in 2022, then slumped by 117 bps to 15377.91% in 2025.
The last three FCF Margin figures came in at 15377.91% (Q3 2025), 88955.56% (Q4 2022), and 4280.33% (Q2 2022), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	29.18%
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	11.58%
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	36.36%
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	7.55%
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	-13.60%
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	15.50%
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	11.56%
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	2.81%
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	5.42%
10	Pulse Biosciences	1.72 Bn	1.72 Bn	-	-

Download Data 🔒